Our Mission
Evaluate novel biologic agents in breast cancer patients to help find new treatments. Recent work has focused on the intrinsic therapy resistance of cancer stem cells, especially the role of inducible nitric oxide signaling in chemoresistance and metastasis.
Jenny C. Chang, MD
Ernest Cockrell, Jr. Presidential Distinguished Chair
Executive Vice President and Chief Academic Officer
President and Chief Executive Officer, Academic Institute
Professor of Medicine, Academic Institute
Full Member, Research Institute, Academic Institute
Houston Methodist
Professor of Medicine, Weill Cornell Medical College
Jenny C. Chang, MB.ChirB., MD, MCHM is the President & CEO of the Houston Methodist Academic Institute and Emily Herrmann Chair in Cancer Research in Houston, Texas.